| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.3M | +6.2% | +3.8% |
| Cost of Revenue | $8.8M | -10.0% | +0.0% |
| Gross Profit | $11.0M | +22.1% | +26.2% |
| R&D Expense | $166K | -32.8% | -45.4% |
| SG&A Expense | $7.9M | +5.0% | +14.1% |
| Operating Income | $3.0M | +131.3% | +93.5% |
| Pre-tax Income | $3.1M | +114.7% | +55.9% |
| Income Tax | $781K | +62.7% | +416.2% |
| Net Income | $1.3M | +427.2% | -8.6% |
| EPS (Basic) | $0.11 | +450.0% | -8.3% |
| EPS (Diluted) | $0.11 | +450.0% | -8.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.7M | -18.7% | -21.5% |
| Accounts Receivable | $16.6M | +114.1% | +205.8% |
| Current Assets | $52.3M | +12.7% | +23.4% |
| Total Assets | $71.9M | +14.7% | +23.7% |
| Current Liabilities | $27.0M | +35.2% | +44.3% |
| Long-term Debt | $386K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$785K | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$2.3M | — | — |
| Financing Cash Flow | $370K | — | — |
| Free Cash Flow | -$2.2M | — | — |
| +1935.0% |
| Total Liabilities | $27.7M | +33.3% | +43.7% |
| Stockholders' Equity | $37.2M | +3.4% | +4.9% |